Lymphoedema is a long-term (chronic) condition that causes swelling in the body’s tissues. It can affect any part of the body, but usually develops in the arms or legs. It develops when the lymphatic system does not work properly. Garnering a CAGR of 4.8% from 2022 to 2028, the global lymphedema treatment market is projected to reach worth of USD 4,722 million by 2028-end, according to a new report by Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global lymphedema treatment market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the lymphedema treatment industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the form, treatment type, end user, and region. The global market for lymphedema treatment can be segmented by form: primary lymphedema, secondary lymphedema. The secondary lymphedema segment held the largest share of the global lymphedema treatment market in 2021 and is anticipated to hold its share during the forecast period. Lymphedema treatment market is further segmented by treatment type: laser therapy, compression devices, drug therapy, physiological procedures, debulking procedures, others. Based on end user, the lymphedema treatment market is segmented into: hospitals, specialty clinics, others. On the basis of region, the lymphedema treatment market also can be divided into: North America, Asia Pacific, Europe, Rest of the World (ROW).

By form:
– primary lymphedema
– secondary lymphedema

By treatment type:
– laser therapy
– compression devices
– drug therapy
– physiological procedures
– debulking procedures
– others

By end user:
– hospitals
– specialty clinics
– others

By region:
– North America
– Asia Pacific
– Europe
– Rest of the World (ROW)

The global lymphedema treatment market report offers detailed information on several market vendors, including AIROS Medical, Inc., Avet Pharmaceuticals Inc., Bio Compression Systems, Inc., BSN medical GmbH (Essity AB), Convatec Inc., Herantis Pharma Plc, Huntleigh Healthcare Limited, Julius Zorn GmbH, Koya Medical, Inc., Lohmann & Rauscher GmbH & Co. KG, Mego Afek A.C. Ltd., SIGVARIS AG, Smith & Nephew plc, Tactile Systems Technology Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
– To analyze and forecast the market size of the global lymphedema treatment market.
– To classify and forecast the global lymphedema treatment market based on form, treatment type, end user, region.
– To identify drivers and challenges for the global lymphedema treatment market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global lymphedema treatment market.
– To identify and analyze the profile of leading players operating in the global lymphedema treatment market.

Why Choose This Report
– Gain a reliable outlook of the global lymphedema treatment market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.